ALEMBIC
Back to Balance Sheet
|
ALEMBIC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹32 Cr | ₹34 Cr | ₹48 Cr | ₹40 Cr | ₹48 Cr |
What is the latest Contingent Liabilities ratio of ALEMBIC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹34 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹48 Cr |
How is Contingent Liabilities of ALEMBIC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | -6.78 | |
| Mar2024 | ₹34 Cr | -29.15 | |
| Mar2023 | ₹48 Cr | 19.69 | |
| Mar2022 | ₹40 Cr | -16.24 | |
| Mar2021 | ₹48 Cr | - | |
Compare Contingent Liabilities of peers of ALEMBIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC | ₹2,370.8 Cr | -1.5% | 22.8% | -13.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,997.0 Cr | 4.1% | -1.3% | -7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,900.0 Cr | 3% | 7.7% | 7.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,804.0 Cr | 2.1% | 0.1% | 26.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,389.0 Cr | 9.3% | 6.6% | 12% | Stock Analytics | |
| CIPLA | ₹106,397.0 Cr | 6.8% | 7.7% | -15.3% | Stock Analytics | |
ALEMBIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | -1.5% |
22.8% |
-13.9% |
| SENSEX | -1.6% |
3.7% |
-2.7% |
You may also like the below Video Courses